Olaratumab January 19, 2018 Olaratumab Trade Name Lartruvo Orphan Indication Soft tissue sarcoma EU Market Approval EU EU Designation Date 2015-02-12 00:00:00 Sponsor Eli Lilly Nederland B.V.
